N-(1RS,2SR)-2-aminocyclohexyl)-4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl)thiophene-2-carboxamide

ID: ALA4568087

PubChem CID: 59603842

Max Phase: Preclinical

Molecular Formula: C21H23N7OS

Molecular Weight: 421.53

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1

Standard InChI:  InChI=1S/C21H23N7OS/c1-27-10-15(8-24-27)14-7-23-20-16(9-25-28(20)11-14)13-6-19(30-12-13)21(29)26-18-5-3-2-4-17(18)22/h6-12,17-18H,2-5,22H2,1H3,(H,26,29)/t17-,18+/m0/s1

Standard InChI Key:  LYADGAGFYYXXIO-ZWKOTPCHSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
    4.8041   -3.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8041   -4.2015    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5094   -4.6060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5094   -2.9716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2147   -3.3843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2146   -4.2025    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9928   -4.4554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4738   -3.7935    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9928   -3.1316    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.2469   -5.2368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7665   -5.8979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2468   -6.5591    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.0241   -6.3066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0240   -5.4894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6852   -6.7869    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5998   -7.5996    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4318   -6.4545    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0929   -6.9349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0036   -7.7469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6607   -8.2267    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4092   -7.8980    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.4967   -7.0846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8356   -6.5998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9208   -5.7871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0976   -2.9787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0098   -2.1662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2099   -1.9987    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8034   -2.7076    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.3520   -3.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9909   -2.7955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  2  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 10  1  0
  7 10  1  0
 13 15  1  0
 15 16  2  0
 15 17  1  0
 18 17  1  1
 18 19  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  1
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 25  2  0
  1 25  1  0
 28 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4568087

   N-[(1R,2S)-2-aminocyclohexyl]-4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]thiophene-2-carboxamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 421.53

Molecular Weight (Monoisotopic): 421.1685

AlogP: 2.86

#Rotatable Bonds: 4

Polar Surface Area: 103.13

Molecular Species: BASE

HBA: 8

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 8

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 9.46

CX LogP: 1.98

CX LogD: -0.04

Aromatic Rings: 4

Heavy Atoms: 30

QED Weighted: 0.53

Np Likeness Score: -1.58

References

1. Sloman DL, Noucti N, Altman MD, Chen D, Mislak AC, Szewczak A, Hayashi M, Warren L, Dellovade T, Wu Z, Marcus J, Walker D, Su HP, Edavettal SC, Munshi S, Hutton M, Nuthall H, Stanton MG..  (2016)  Optimization of microtubule affinity regulating kinase (MARK) inhibitors with improved physical properties.,  26  (17): [PMID:27491711] [10.1016/j.bmcl.2016.02.003]

Source

Source(1):

• Scientific Literature